Pipeline – Anison Therapeutics

Pipeline

https://anisontherapeutics.com/wp-content/uploads/2022/09/pipeline.001-1-1920x550.png

Anison is currently working with suitable partners for drug substance and drug product development

Cultivation and Continuous supply of Raw Material under GACP
Drug Substance (API) - GMP Feasibility & Analytical Development
Drug Product - Formulation & Analytical Development

Cultivation

Cultivation Partner

100%

Continuous Supply of Raw(plant) Material

100%

Material for API Development

100%

Material for GMP

34%

Progress

API Development

GMP Partner

100%

GMP Production Feasibility

100%

Light GMP Material for Pre-clinical

96%

GMP Production

22%

Progress

Drug Product Development

GMP Partner

100%

Formulation Development

15%

Analytical Development

10%

GMP Production

10%

Progress

© Anison Therapeutics Oy